WallStreetZenWallStreetZen

NASDAQ: HCM
Hutchmed Ltd Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

HCM past revenue growth

How has HCM's revenue growth performed historically?
Company
96.52%
Industry
9.98%
Market
17.61%
HCM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
HCM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
HCM's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

HCM earnings and revenue history

Current Revenue
$838.0M
Current Earnings
$100.8M
Current Profit Margin
12%
HCM's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

HCM Return on Equity

Current Company
15%
Current Industry
15.4%
Current Market
188%
HCM's Return on Equity (15%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when HCM announces earnings.

HCM Return on Assets

Current Company
8.7%
Current Industry
3.4%
HCM is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

HCM Return on Capital Employed

Current Company
12.1%
Current Industry
5.1%
HCM has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

HCM vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
HCM$838.00MN/A$100.78M+31.38%N/A
INDV$1.09B$67.00M$2.00M-0.40%-67.60%
BHC$8.76B$2.22B-$592.00M+0.88%N/A
EVON/AN/AN/AN/AN/A
PBH$1.13B$16.86M-$80.67M+2.74%N/A
View Top Pharmaceutical Stocks

Hutchmed Earnings & Revenue FAQ

What were HCM's earnings last quarter?

On Invalid Date, Hutchmed (NASDAQ: HCM) reported Q4 2023 earnings per share (EPS) of N/A, up N/A year over year. Total Hutchmed earnings for the quarter were N/A. In the same quarter last year, Hutchmed's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Hutchmed stock.

What was HCM's earnings growth in the past year?

As of Q2 2024, Hutchmed's earnings has grown year over year. Hutchmed's earnings in the past year totalled $100.78 million.

What was HCM's revenue last quarter?

On Invalid Date, Hutchmed (NASDAQ: HCM) reported Q4 2023 revenue of N/A up N/A year over year. In the same quarter last year, Hutchmed's revenue was N/A.

What was HCM's revenue growth in the past year?

As of Q2 2024, Hutchmed's revenue has grown 96.52% year over year. This is 86.55 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 9.98%. Hutchmed's revenue in the past year totalled $838.00 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.